Medical device-focused CRO Genae has invested an undisclosed amount in Meditrix, a Japanese CRO in that same field, and obtained a call option to acquire the…

Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia.

PPD has expanded its vaccine sciences lab in Richmond, Virginia, by another 17,000 square feet and added vaccine efficacy testing capacity using cell-based…

LabCorp is planning a rejig of its CRO business Covance, and the short-term plan includes letting go of a lab along with the employees stationed there.

Singapore’s state-owned investment firm Temasek and Chinese internet tycoon Jack Ma-backed Yunfeng Capital have led a $75 million Series B into WuXi NextCODE.

The Abu Dhabi Investment Authority and Singapore’s GIC have bought a minority stake in PPD, valuing the CRO giant at more than $9 billion.

NCGS is expanding its business by relocating to a new corporate headquarters, bringing $10 million in investment and creating 80 new jobs.

Amid new approvals last year, drugmakers also suffered R&D setbacks, cut research staff, rejigged their operations and refocused their pipelines.